Lichen China (NASDAQ:LICN) & Astrana Health (NASDAQ:ASTH) Head to Head Analysis

Astrana Health (NASDAQ:ASTH) and Lichen China (NASDAQ:LICN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Insider & Institutional Ownership

52.8% of Astrana Health shares are held by institutional investors. 8.5% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Astrana Health and Lichen China”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$1.59 billion	2.01	$60.72 million	$1.32	43.18
Lichen China	$39.76 million	1.26	$8.34 million	N/A	N/A

Astrana Health has higher revenue and earnings than Lichen China.

Analyst Recommendations

This is a summary of recent ratings for Astrana Health and Lichen China, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	0	4	1	3.20
Lichen China	0	0	0	0	N/A

Astrana Health currently has a consensus target price of $59.00, suggesting a potential upside of 3.51%. Given Astrana Health’s higher probable upside, analysts plainly believe Astrana Health is more favorable than Lichen China.

Profitability

This table compares Astrana Health and Lichen China’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	4.30%	10.71%	6.10%
Lichen China	N/A	N/A	N/A

Risk & Volatility

Astrana Health has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Lichen China has a beta of -2.68, meaning that its share price is 368% less volatile than the S&P 500.

Summary

Astrana Health beats Lichen China on 12 of the 12 factors compared between the two stocks.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

About Lichen China

Lichen China Limited, together with its subsidiaries, operates as an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China and internationally. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sells teaching and learning materials. It also provides Lichen Education Accounting Practice System V1.0, a financial and taxation training software, and academic affairs management system to partnered institutions under the partnership agreements, as well as offers software installation, training, and after sales technical and maintenance support services. Lichen China Limited was founded in 2004 and is based in Jinjiang, China.